Electropharmacology, Inc. creates novel products for the improved treatment of complex human diseases such as cancer, wounds, chronic infections, inflammation and tissue degeneration. The company's drug technology can be applied without using needles and pumps. The company also develops proprietary devices that deliver pulsed electromagnetic signals to increase local blood flow. Through Gemini Biotech, Ltd. a partnership, the company also makes and sells custom products for genomics research and drug discovery to acadamic researchers and biopharmaceutical companies. The company acquired minority interest of Gemini Health Technologies Limited Partnership in 1999.
